KHRN.F Stock Overview
Operates as an integrated medical and cannabis company in Latin America and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Khiron Life Sciences Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.02 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.99% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| KHRN.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.0% |
| 1Y | -100.0% | 13.7% | 32.4% |
Return vs Industry: KHRN.F underperformed the US Pharmaceuticals industry which returned 11.8% over the past year.
Return vs Market: KHRN.F underperformed the US Market which returned 32.6% over the past year.
Price Volatility
| KHRN.F volatility | |
|---|---|
| KHRN.F Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine KHRN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Alvaro Torres | khiron.ca |
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
Khiron Life Sciences Corp. Fundamentals Summary
| KHRN.F fundamental statistics | |
|---|---|
| Market cap | US$232.00 |
| Earnings (TTM) | -US$21.80m |
| Revenue (TTM) | US$11.47m |
0.0x
P/S Ratio0.0x
P/E RatioIs KHRN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KHRN.F income statement (TTM) | |
|---|---|
| Revenue | CA$16.14m |
| Cost of Revenue | CA$9.47m |
| Gross Profit | CA$6.67m |
| Other Expenses | CA$37.33m |
| Earnings | -CA$30.66m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did KHRN.F perform over the long term?
See historical performance and comparison